BRAND_ANALYSIS #GLAXOSMITHKLINE HEALTH & PHARMA #4 OF 26 IN HEALTH & PHARMA INTERESTING

GlaxoSmithKline

· Public · Updated 22 Nov 2026 07:19 UTC
#66 of 1208 overall by tension · #4 of 26 in Health & Pharma
26 Interesting
The Silent Giant
Analysis

C=35, B=61, down 5.9% — GSK is a pharmaceutical giant in the middle of a prolonged identity crisis, having spun off Haleon and rebranded while litigation risk from Zantac haunts the balance sheet. The lowest C score in this batch for a reason: nobody has a relationship with GSK, they just occasionally take its drugs. T=26 is generous.

IN THE NEWS (10 articles this week)
GSK plc (GSK) Stock Price, News, Quote & History - Yahoo! Finance Canada
Barclays Reaffirms Their Sell Rating on GlaxoSmithKline (GSK) - The Globe and Mail
GSK plc (GSK.L) Stock Price, News, Quote & History - Yahoo! Finance Canada
Cultural Score
35 / 100
Business Score
61 / 100
TENSION▃▃▂▂▂▃▂▃▃▃▃▃▃▂
CULTURAL▃▃▄▄▃▃▃▃▃▃▃▃▃▃
BUSINESS▆▆▅▅▅▅▅▅▅▆▅▆▆▅
Loading...
Wikipedia Momentum 15/40
News Presence 20/35
Search InterestRedistributed to other dimensions
Stock Momentum 12/30
Market Position 19/25
Revenue Growth 15/25
Earnings Health 15/20
Price$47.76
30d Change-5.9%
Market Cap$95.7B
Profit Margin13.0%
GlaxoSmithKline's tension is 26. Commerce outpacing culture. sociologyofcapitalism.com/brand/glaxosmithkline
SHARE ON X
EMBED
<iframe src="https://sociologyofcapitalism.com/embed/glaxosmithkline.html" width="320" height="200" frameborder="0"></iframe>